Effects of the desensitization by morphine of the opiate-dependent adenylate cyclase system in the rat striatum on the activity of the inhibitory regulatory G protein

doi:10.1016/0006-2952(88)90507-2

Biochemical Pharmacology

Volume 37, Issue 6, 15 March 1988, Pages 1039-1044

https://doi.org/10.1016/0006-2952(88)90507-2 Get rights and content

Abstract

Opiates act through a specific receptor to inhibit the striatal adenylate cyclase [ATP pyrophosphate-lyase (cyclizing), EC 4.6.1.1] and stimulate a high-affinity GTPase (EC 3.6.1). The present study analyzes the functions of the striatal adenylate cyclase complex following chronic morphine treatment in the rat. The inhibitory effects of GTP on basal adenylate cyclase activity, between 10⁻⁶ and 10⁻⁴ M, were reduced. Moreover, the half-maximal inhibitory concentration of the opiate receptor agonist (d-Ala²Met⁵-enkephalinamide (DAME) on striatal adenylate cyclase activity was increased by about four times, whereas the maximal effect was reduced in membranes from treated rats. In parallel, the half-maximal stimulatory concentration of DAME on GTPase was increased by two times, and the maximal stimulation was reduced from 60 to 25%. Binding studies performed with [3,5-³] DAME (saturation curves) and with [³H]naloxone (competition curves) did not show any change in opiate receptor numbers and affinity. Moreover, the kinetics of the activation of the inhibitory GTP binding protein (G_i) which transduces the opiate receptor effect on adenylate cyclase showed a small but significant delay. Therefore, hypofunction of G_i can be, at least in part, responsible for the observed desensitization by morphine of the opiate-dependent GTPase and adenylate cyclase.

References (32)

D.M.F. Cooper
Fedn Eur. Biochem. Soc. Lett.
(1982)
A.G. Gilman
Cell
(1984)
M. Wüster et al.
Life Sci.
(1983)
T. Costa et al.
Life Sci.
(1983)
D.L. Greenspan et al.
Neuropeptides
(1984)
M. Wüster et al.
Trends pharmac. Sci.
(1985)
M. Parenti et al.
Life Sci.
(1983)
M.M. Bradford
Analyt. Biochem.
(1976)
D. Cassel et al.
Biochim. biophys. Acta
(1976)
Y. Salomon et al.
Analyt. Biochem.
(1974)

P.J. Munson et al.

Analyt. Biochem.

(1980)

T. Katada et al.

J. biol. Chem.

(1984)

M.E. Abood et al.

Biochem. biophys. Res. Commun.

(1985)

T. Sunyer et al.

J. biol. Chem.

(1984)

L. Vachon et al.

Biochem. biophys. Res. Commun.

(1985)

K. Seamon et al.

J. biol. Chem.

(1981)

Cited by (17)

Oxygen radical disease in the newborn, revisited: Oxidative stress and disease in the newborn period
2019, Free Radical Biology and Medicine
Citation Excerpt :
can directly attack DNA bases, leading to the formation of 5-hydroxymethylcytosine (5hmC) from 5-methylcytosine (5 mC). 5hmC can then lead to indirect demethylation of CpG sites resulting in changes in gene transcription [132,133]. An example of lasting epigenetic effect of oxygen in the newborn period was published in 2012, where adult rats exposed to hypoxic episodes in the neonatal period showed increased sleep disordered breathing and hypertension thought to be a result of DNA methylation in redox genes [134].
Thirty years ago, there was an emerging appreciation for the significance of oxidative stress in newborn disease. This prompted a renewed interest in the impact of oxygen therapy for the newborn in the delivery room and beyond, especially in premature infants. Today, the complexity of oxidative stress both in normal regulation and pathology is better understood, especially as it relates to neonatal mitochondrial oxidative stress responses to hyperoxia. Mitochondria are recipients of oxidative damage and have a propensity for oxidative self-injury that has been implicated in the pathogenesis of neonatal lung diseases. Similarly, both intrauterine growth restriction (IUGR) and macrosomia are associated with mitochondrial dysfunction and oxidative stress. Additionally, reoxygenation with 100% O₂ in a hypoxic-ischemic newborn lamb model increased the production of pro-inflammatory cytokines in the brain. Moreover, the interplay between inflammation and oxidative stress in the newborn is better understood because of animal studies. Transcriptomic analyses have found a number of genes to be differentially expressed in murine models of bronchopulmonary dysplasia (BPD). Epigenetic changes have also been detected both in animal models of BPD and premature infants exposed to oxygen. Antioxidant therapy to prevent newborn disease has not been very successful; however, new therapeutic principles, like melatonin, are under investigation.
Sensitization of the locomotor response to psychostimulants after repeated opiate exposure: Role of the nucleus accumbens
1997, Neuropsychopharmacology
The following experiments were performed to ascertain the role of the nucleus accumbens in opiate-dopamine interactions using measures of locomotor activity. Three separate experiments were carried out. In Experiment 1, rats received systemic morphine (10 mg/kg IP) or saline (1 ml/kg IP) every other day for 5 days, followed by systemic amphetamine (1.5 mg/kg) 48 hours following the fifth injection. Animals in the morphine pretreatment group exhibited a sensitized locomotor response to amphetamine. In Experiment 2, animals received the same systemic pretreatment and were subsequently given intraaccumbens saline, amphetamine (2.5 μg/0.5 μl) or cocaine (7 μg/0.5 μl), each separated by 48 hours. Morphine-pretreated animals showed enhanced motor activity in response to intraaccumbens microinfusion of the psychostimulant drugs. Finally, in Experiment 3, multiple microinjections of morphine (0.5 μg/0.5 /μl) directly into the nucleus accumbens resulted in a potentiated locomotor response to intraaccumbens amphetamine (2.5 μg/0.5 μl). These data indicate that the nucleus accumbens may contribute to both the development and expression of opiate-stimulant crosssensitization. The neural basis of this sensitization is hypothesized to be a common intracellular pathway affected by both classes of drugs, such as the cyclic adenosine monophosphate (AMP) system.
Opioid receptor-coupled G-proteins in rat locus coeruleus membranes: Decrease in activity after chronic morphine treatment
1997, Brain Research
The nucleus locus coeruleus is involved in the expression of opiate physical dependence and withdrawal, and has been characterized extensively with regard to chronic morphine-induced alterations in biochemical and electrophysiological responses. In the present study, the effects of chronic morphine treatment on opioid receptor-coupled G-protein activity was investigated in membranes from rat locus coeruleus. Opioid agonists stimulated low K_m GTPase activity with pharmacology consistent with mu receptors. Chronic morphine treatment resulted in decreases in both basal and opioid-stimulated low K_m GTPase activity, with no change in the percent stimulation by agonist. The decrease in low K_m GTPase activity appeared to be due to a decrease in the V_max of the enzyme, with no change in the K_m for GTP hydrolysis. These results were confirmed by assays of basal and opioid receptor-stimulated [³⁵S]GTPγS binding in the presence of excess GDP. Thus, chronic morphine treatment apparently decreased inhibitory G-protein activity in the locus coeruleus without producing any detectable desensitization. These results suggest a potential adaptation at the receptor/transducer level which may contribute to other biochemical changes produced in the locus coeruleus by chronic morphine treatment.
Functional studies on opioid receptor heterogeneity in the central nervous system
1994, Neurochemistry International
Repeated and chronic morphine administration causes differential long-lasting changes in dopaminergic neurotransmission in rat striatum without changing its δ- and κ-opioid receptor regulation
1994, European Journal of Pharmacology
Repeated, once daily morphine treatment (14 days) as well as chronic morphine administration (6 days) caused a rebound reduction in the electrically evoked release of [³H]dopamine from superfused rat striatal slices 1 day after the last subcutaneous injection. Interestingly, whereas [³H]dopamine release remained significantly reduced for at least 3 weeks following morphine withdrawal in chronically treated (tolerant/dependent) rats, neurotransmitter release from dopaminergic nerve terminals gradually increased above control values following cessation of repeated morphine administration. Postsynaptically, dopamine D₁ receptor-stimulated adenylate cyclase appeared to be sensitized 1–3 days but was unchanged 3 weeks after chronic morphine treatment. In contrast, such an enhanced postsynaptic dopamine D₁ receptor efficacy did not occur 1–3 days following repeated morphine administration, but appeared to develop slowly resulting in a profound increase of dopamine-sensitive adenylate cyclase 3 weeks after the last injection. The inhibitory effect of dynorphin A-(1–13) on [³H]dopamine release, as well as that of [Met⁵]enkephalin on dopamine D₁ receptor-stimulated adenylate cyclase appeared to be unchanged subsequent to repeated or chronic morphine treatment. These data indicate that, long after cessation of drug treatment, chronic morphine treatment causes a reduction whereas repeated morphine administration gradually induces an enhancement of opioid receptor-regulated dopaminergic neurotransmission due to local adaptive changes within the rat striatum. Such distinct long-lasting alterations of dopaminergic neurotransmission induced by different temporal patterns of morphine administration in projection areas of mesencephalic dopaminergic neurons may be related to the enduring effects of drug abuse such as behavioural sensitization and drug craving.
In situ hybridization reveals specific increases in Gα<inf>s</inf> and Gα<inf>o</inf> mRNA in discrete brain regions of morphine-tolerant rats
1993, European Journal of Pharmacology: Molecular Pharmacology
In situ hybridization histochemistry has been used to detect the basal distribution of mRNA encoding the α subunit of G_s, G_o and G_i2 proteins throughout the rat brain. Based on these data we investigated the effect of chronic morphine on the content of these G protein α subunits mRNA. We observed an increase in the expression of α_s and α_o messages of chronically morphine-treated animals, while no changes were seen in α_i2 mRNA. Specifically a 30% increase in expression for α_s was seen only in the paraventricular nucleus of hypothalamus and a 20% elevation for α_o was detected in the claustrum and endopiriform nucleus. Immunoblotting analysis was used to correlate the changes in α_s and α_o messages with equivalent changes in protein levels. Chronic morphine significantly increased α_s amounts in the hypothalamus (70%), and produced a minor elevation (30%) in Gα_o levels in the olfactory area. Our results indicate that in discrete brain regions altered G protein expression is part of the adaptive changes underlying opiate tolerance.

View all citing articles on Scopus

View full text

Effects of the desensitization by morphine of the opiate-dependent adenylate cyclase system in the rat striatum on the activity of the inhibitory regulatory G protein

Abstract

Fedn Eur. Biochem. Soc. Lett.

Cell

Life Sci.

Life Sci.

Neuropeptides

Trends pharmac. Sci.

Life Sci.

Analyt. Biochem.

Biochim. biophys. Acta

Analyt. Biochem.

Analyt. Biochem.

J. biol. Chem.

Biochem. biophys. Res. Commun.

J. biol. Chem.

Biochem. biophys. Res. Commun.

J. biol. Chem.